During the past decade, Hospital Geral de Nova Iguaçú conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Geral de Nova Iguaçú" #1 sponsor was "International Maternal Pediatric Adolescent AIDS Clinical Trials Group" with 2 trials, followed by "AIDS Clinical Trials Group" with 1 trials sponsored, "Fundación Huésped" with 1 trials sponsored, "Hospital Moinhos de Vento" with 1 trials sponsored and "Max O'Donnell" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Geral de Nova Iguaçú" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Amazon.com, Inc." with 1 trials as a collaborator, "Federal University of Bahia" with 1 trials as a collaborator and "Ministry of Health, Brazil" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Geral de Nova Iguaçú" are "HIV Infection" (2 trials), "Delirium" (1 trials), "HIV Infections" (1 trials), "HIV-1" (1 trials) and "HIV-1-infection" (1 trials). Many other conditions were trialed in "Hospital Geral de Nova Iguaçú" in a lesser frequency.

Most popular intervention types in "Hospital Geral de Nova Iguaçú" are "Drug" (4 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cohort 1" (1 trials), "Comparator ARM: TDF/XTC plus Dolutegravir (XTC stand for lamivudine OR emtricitabine)" (1 trials), "Convalescent Plasma (anti-SARS-CoV-2 plasma)" (1 trials), "Etravirine" (1 trials) and "Flexible Family Visitation Model (FFVM)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Geral de Nova Iguaçú" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Geral de Nova Iguaçú". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital Geral de Nova Iguaçú, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Geral de Nova Iguaçú, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".